Mehow Innovative

Mehow Innovative ROCE

The Return on Capital Employed (ROCE) of Mehow Innovative (301363.SZ) as of Oct 21, 2026 is 9.07 %. In the previous year, Return on Capital Employed (ROCE) was 10.70 % — a change of -15.19% (lower).

ROCE

9.07 %

YoY

-15.19%

Last updated:

In 2025, Mehow Innovative's return on capital employed (ROCE) was 9.07 %, a -15.19% increase from the 10.70 % ROCE in the previous year.

The Mehow Innovative ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2020
27.35 CNY
Jan 1, 2021
26.38 CNY
Jan 1, 2022
13.53 CNY
Jan 1, 2023
9.54 CNY
Jan 1, 2024
10.70 CNY
Jan 1, 2025
9.07 CNY
The Mehow Innovative ROCE history
YEARROCEYoY
9.07 %-15.19%
10.70 %+12.14%
9.54 %-29.50%
13.53 %-48.70%
26.38 %-3.57%
27.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mehow Innovative Stock analysis

What does Mehow Innovative do? Mehow Innovative Ltd. generates revenue through the design, development, manufacturing, and services of medical equipment. The company offers full-process services from product design and development to mass production and delivery for domestic and foreign medical device customers. Its main products include home ventilator components, precision molds and automation equipment, cochlear implant components, and spirometers. These components are primarily used in the production of household ventilators and cochlear implant products. The firm distributes its products in both domestic and overseas markets, serving medical device manufacturers and healthcare providers who require specialized equipment and components for their production processes. Mehow Innovative Ltd. focuses on providing comprehensive solutions for medical device manufacturers, including home ventilator components and cochlear implant components. The company's precision molds and automation equipment support the manufacturing of various medical devices, while spirometers are offered as standalone medical device products. Domestic and overseas markets represent key segments for the company's product distribution, with a particular emphasis on serving clients involved in the production of ventilators and cochlear implants. The firm's services extend from initial design to final delivery, ensuring end-to-end support for its customers' medical device needs. The company's revenue streams are derived from the sale of home ventilator components, precision molds, automation equipment, cochlear implant components, and spirometers. These products cater to the needs of medical device manufacturers who require specialized components for household ventilators and cochlear implant systems. By offering full-process services, Mehow Innovative Ltd. positions itself as a key supplier in the medical equipment sector, serving both domestic and international clients across multiple market segments. Mehow Innovative is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Mehow Innovative's Return on Capital Employed (ROCE)

Mehow Innovative's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Mehow Innovative's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Mehow Innovative's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Mehow Innovative’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Mehow Innovative stock

Return on Capital Employed (ROCE) of Mehow Innovative is 9.07 % in 2025.

Return on Capital Employed (ROCE) of Mehow Innovative changed from 10.70 % to 9.07 %, representing a -15.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Mehow Innovative since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Mehow Innovative with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Mehow Innovative

All Key Metrics — Mehow Innovative